Skip to main content

French refusal to pull up GMO "contaminated" maize splits government

artificial gene constructs are causing political controversy in France.

Written byRobert Walgate
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

LONDON, 18 July (Science Analysed) Members of the French Government are taking different sides after a surprise announcement on 14 July that the Government will not pull up some 4 500 hectares of "contaminated" maize, parts per thousand of whose seeds have been found to contain artificial and unauthorized Bacillus thuringiensis gene constructs.The discovery was revealed last week in a regional newspaper, Le Quotedien du Sud-Ouest, but had been known to the Government since February, a spokesman for the French agricultural research institute, l'Institut National de la Recherche Agronomique (INRA) told BioMed Central today (18 July).

The contamination had been detected by a government consumer protection agency, the DGCCRF (Direction Generale de la Consommation et de la Repression des Fraudes), whose discoveries were then leaked to the local paper.

According to INRA, the contaminating gene constructs involved are an approved Novartis B.th. construct, and another similar construct called B.th. 11, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Considerations for Selecting Molecular Methods for Biomarker Assessment in Hematologic Malignancies

Considerations for Selecting Molecular Methods for Biomarker Assessment in Hematologic Malignancies

Qiagen Logo
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays